These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17471998)
61. Improving the science for botanical and dietary supplements. Geller SE Altern Ther Health Med; 2009; 15(1):16-7. PubMed ID: 19161043 [No Abstract] [Full Text] [Related]
62. Role of papaverine hydrochloride administration in patients with intractable renal colic: randomized prospective trial. Yencilek F; Aktas C; Goktas C; Yilmaz C; Yilmaz U; Sarica K Urology; 2008 Nov; 72(5):987-90. PubMed ID: 18789511 [TBL] [Abstract][Full Text] [Related]
63. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Fry AC; Singh S; Gunda SS; Boustead GB; Hanbury DC; McNicholas TA; Farrington K Nephron Clin Pract; 2008; 108(3):c213-20. PubMed ID: 18332635 [TBL] [Abstract][Full Text] [Related]
64. Effects of supervised treadmill walking training on calf muscle capillarization in patients with intermittent claudication. Wang J; Zhou S; Bronks R; Graham J; Myers S Angiology; 2009; 60(1):36-41. PubMed ID: 18505746 [TBL] [Abstract][Full Text] [Related]
65. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. Ewers B; Riserus U; Marckmann P J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503 [TBL] [Abstract][Full Text] [Related]
66. [Herbal drug kanefron H in postoperative metaphylaxis of urolithiasis]. Amosov AV; Aliaev IuG; Saenko VS Urologiia; 2010; (5):65-71. PubMed ID: 21254644 [No Abstract] [Full Text] [Related]
67. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447 [TBL] [Abstract][Full Text] [Related]
68. Dietary supplementation by Japanese patients with chronic obstructive pulmonary disease. Hirayama F; Lee AH; Binns CW; Taniguchi H Complement Ther Med; 2009 Jan; 17(1):37-43. PubMed ID: 19114227 [TBL] [Abstract][Full Text] [Related]
69. [Selenium deficiency and its dietary correction in patients with irritable bowel syndrome and chronic catarrhal colitis]. Bogatov NV Vopr Pitan; 2007; 76(3):35-9. PubMed ID: 17674518 [TBL] [Abstract][Full Text] [Related]
70. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. Maina G; Rosso G; Bogetto F J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001 [TBL] [Abstract][Full Text] [Related]
71. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis. Chazan B; Raz R; Shental Y; Sprecher H; Colodner R Isr Med Assoc J; 2008 Feb; 10(2):164-5. PubMed ID: 18432039 [No Abstract] [Full Text] [Related]
72. [Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis]. Kazeko NI; Zhmurov VA; Borovskiĭ AA; Veshkurtsev VV; Khvan OV Urologiia; 2005; (5):56-8. PubMed ID: 16281843 [TBL] [Abstract][Full Text] [Related]
73. [Features of urolithiasis in patients of advanced and senile age.]. Аgenosov MP; Каgan OF; Khеyfets VK Adv Gerontol; 2018; 31(3):368-373. PubMed ID: 30584876 [TBL] [Abstract][Full Text] [Related]
74. [Specific features of the immune status and blebbing of the plasmatic membrane of lymphocytes patients with urolithiasis complicated by the pyelonephritis]. Berezhnoy AG; Sevryukov FA; Vinnik YY; Kapsargin FP Urologiia; 2019 Dec; (5):60-63. PubMed ID: 31808634 [TBL] [Abstract][Full Text] [Related]
75. [The use of laser radiation and sinusoidal modulated currents in the therapy of patients with chronic calculous pyelonephritis]. Nesterov NI; Li AA; Vasil'eva MF; Slepushkina TG; Derevnina NA Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (4):24-5. PubMed ID: 10513467 [TBL] [Abstract][Full Text] [Related]
76. [Role of phytotherapy in the treatment of urolithiasis]. Maksimov VA; Iarovoĭ SK; Aleksandrov NS; Maksudov RR Urologiia; 2012; (3):58, 60-1. PubMed ID: 23074938 [No Abstract] [Full Text] [Related]
77. Could the urolithiasis be treated by anti-nanobacterial therapy? Liu GL; Zheng XY; Xie LP Med Hypotheses; 2010 Apr; 74(4):755. PubMed ID: 20022710 [No Abstract] [Full Text] [Related]
78. [Phytotherapy--one more possibility in the treatment of premenstrual syndrome]. Lazarov I Akush Ginekol (Sofiia); 2006; 45 Suppl 2():40-4. PubMed ID: 16922346 [No Abstract] [Full Text] [Related]
79. [Certain principles of prevention and treatment of acute inflammatory kidney diseases]. Zil'berman MN; Litvinenko AG; Saĭfutdinov RA; Golovchenko AI; Chirkov AM Sov Med; 1975 Jul; (7):77-80. PubMed ID: 1216056 [No Abstract] [Full Text] [Related]
80. The greatest untapped food resource on earth? Davys G Public Health Nutr; 2009 Jan; 12(1):142. PubMed ID: 19087377 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]